authors
- Maile Young Karris, MD
- Sun, Xiaoying
- Daar, Eric S
- Haubrich, Richard H
- Morris, Sheldon
- Jain, Sonia
- Bowman, Vi Q
- Rieg, Gunter
- Goicoechea, Miguel
- Dube, Michael P
- Kerkar, Shubha
- Kemper, Carol
- Diamond, Catherine
Nucleoside-Sparing Regimens With Raltegravir and a Boosted Protease Inhibitor: An Unsettled Issue.
- Overview
- Identity
- Additional Document Info
- View All
Overview
publication date
- January 1, 2016
published in
has subject area
- Adult
- Alkynes
- Anti-HIV Agents
- Atazanavir Sulfate
- Benzoxazines
- Cyclopropanes
- Dose-Response Relationship, Drug
- Drug Therapy, Combination
- Emtricitabine
- Female
- HIV Infections
- HIV Protease Inhibitors
- Humans
- Lopinavir
- Male
- Middle Aged
- RNA, Viral
- Raltegravir Potassium
- Ritonavir
- Surveys and Questionnaires
- Tenofovir
- Treatment Outcome